首页> 外文期刊>In vivo. >MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells
【24h】

MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells

机译:MicroRNA-1和MicroRNA-21分别调节非恶性和恶性肾细胞的细胞生长。

获取原文
获取外文期刊封面目录资料

摘要

Background/Aim: Due to its poor prognosis, it is increasingly necessary to understand the biology of renal cell cancer (RCC). Therefore, we investigated the role of microRNAs miR-1 and miR-21 in the growth of RCC cells compared to that of non-malignant renal cells. Materials and Methods: Four malignant cell lines (Caki-1, 786-O, RCC4, A498) were examined regarding their cell growth, microRNA and telomerase expression, and were compared to non-malignant RC-124 renal cells. Results: Inconsistencies appeared in the panel of RCC cells regarding antiproliferative and proliferative properties of miR-1 and miR-21, respectively. Notably, and most likely due to immortaliziation, non-malignant RC-124 cells exhibited telomerase expression and activity. Conclusion: miR-1 and miR-21 functionality in cancer progression, particularly in tumor growth, may be more dependent on the individual cellular context and may reflect RCC heterogeneity. Thus, both microRNAs, in combination with other stratifying biomarkers, may be useful in terms of RCC diagnosis, prognosis, or treatment response.
机译:背景/目的:由于其预后较差,因此越来越需要了解肾细胞癌(RCC)的生物学。因此,我们研究了与非恶性肾细胞相比,microRNA miR-1和miR-21在RCC细胞生长中的作用。材料和方法:检查了四种恶性细胞系(Caki-1、786-O,RCC4,A498)的细胞生长,microRNA和端粒酶表达,并与非恶性RC-124肾细胞进行了比较。结果:RCC细胞小组分别关于miR-1和miR-21的抗增殖和增殖特性出现不一致。值得注意的是,并且最有可能由于永生化,非恶性RC-124细胞表现出端粒酶表达和活性。结论:miR-1和miR-21在癌症进展中,特别是在肿瘤生长中的功能,可能更多地取决于个体细胞情况,并可能反映RCC异质性。因此,两种微小RNA与其他分层生物标志物的组合,在RCC诊断,预后或治疗反应方面可能是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号